Patient groups create the building blocks for life science innovation by funding early stage research, engaging patients, and more. They're critical but lack tools to do what they do. At Comend, we're building the tools. Our mission is to empower people to develop treatments for their loved ones in the long tail of disorders. Our vision is of a world full of patient-led biotechs. To date, we've released a crowdsourced search platform for disability resources and an AI-powered scientific translator. Our core product (launching March 2025) is a marketplace for rare disease research. All of our products are co-designed with the rare community. https://calendly.com/albertatcomend/comend-convos Backed by Character VC and Drive Capital.
Investors 2
| Date | Name | Website |
| 22.02.2024 | Character | character.... |
| 10.08.2025 | NEXT Canad... | directory.... |